Treatment Landscape for Metastatic Castrate-Sensitive Prostate Cancer: A Review

With the advent of new therapeutic modalities, management of metastatic castrate-sensitive prostate cancer (mCSPC) has been in flux. From androgen-deprivation therapy to docetaxel to androgen receptor–signaling inhibitors, each agent has heralded a new treatment paradigm. As such, the optimal first-...

Descripción completa

Detalles Bibliográficos
Autores principales: Meagher, Margaret F, Salmasi, Amirali, Stewart, Tyler F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655601/
https://www.ncbi.nlm.nih.gov/pubmed/38025805
http://dx.doi.org/10.2147/RRU.S398129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655601/
https://www.ncbi.nlm.nih.gov/pubmed/38025805
http://dx.doi.org/10.2147/RRU.S398129

Ejemplares similares